Market Overview

US Stock Futures Jump Ahead Of GDP Report

Share:
US Stock Futures Jump Ahead Of GDP Report
Related ACTG
Acacia Research Owns More In Veritone Than Its Own Market Cap
20 Biggest Mid-Day Losers For Wednesday
Related
Genmab Announces $3M Milestone Payment in DuoBody Platform Collaboration with Janssen
Genmab Reaches $3M Milestone Payment in DuoBody Platform Collaboration with Janssen
Novartis to transition availability of Arzerra for CLL to compassionate use ex-U.S., $50M milestone to partner Genmab (Seeking Alpha)

Pre-open movers

US stock futures traded higher in early pre-market trade. Data on GDP growth for the second quarter will be released at 8:30 a.m. ET. The Flash Services PMI for September will be released at 9:45 a.m. ET, while the University of Michigan's consumer sentiment index for September will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average jumped 203 points to 16,302.0, while the Standard & Poor's 500 index futures rose 21 points to 1,939.75. Futures for the Nasdaq 100 index surged 42.25 points to 4,288.25.

A Peek Into Global Markets

European markets were lower today, with the Spanish Ibex Index gaining 2.44 percent, STOXX Europe 600 Index surging 2.92 percent and German DAX 30 index surging 2.52 percent. French CAC 40 Index jumped 3.17 percent and London's FTSE 100 Index rose 2.38 percent.

In Asian markets, Japan's Nikkei Stock Average rose 1.76 percent, Hong Kong's Hang Seng Index gained 0.43 percent, China's Composite Index Index fell 1.60 percent.

Broker Recommendation
Analysts at Goldman Sachs upgraded ACE Limited (NYSE: ACE) from Neutral to Buy and raised the price target from $112.00 to $116.00.

ACE shares rose 0.21 percent to close at $101.55 yesterday.

Breaking news

  • Acacia Research Corp (NASDAQ: ACTG) announced today that its Bonutti Skeletal Innovations LLC subsidiary has entered into a settlement and patent license agreement with Zimmer Biomet Holdings, Inc. To read the full news, click here.
  • Genmab A/S (OTC: GNMSF) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has granted accelerated assessment to the Marketing Authorization Application (MAA) for daratumumab. To read the full news, click here.
  • Mercer has entered into a strategic alliance with Transamerica whereby Transamerica will acquire Mercer's US defined contribution (DC) administration book of business. To read the full news, click here.
  • Nike Inc (NYSE: NKE) reported stronger-than-expected results for its fiscal first quarter on Thursday. To read the full news, click here.

Posted-In: Goldman Sachs US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (ACTG + ACE)

View Comments and Join the Discussion!